Kovack Advisors, Inc. Kempharm, Inc Transaction History
Kovack Advisors, Inc.
- $907 Million
- Q1 2025
A detailed history of Kovack Advisors, Inc. transactions in Kempharm, Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 146,747 shares of KMPH stock, worth $724,930. This represents 0.08% of its overall portfolio holdings.
Number of Shares
146,747
Previous 146,158
0.4%
Holding current value
$724,930
Previous $722,000
0.28%
% of portfolio
0.08%
Previous 0.07%
Shares
16 transactions
Others Institutions Holding KMPH
# of Institutions
121Shares Held
31.8MCall Options Held
186KPut Options Held
597K-
Woodline Partners LP San Francisco, CA4.62MShares$22.8 Million0.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.62MShares$17.9 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.47MShares$7.27 Million0.33% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...